These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 34805268)

  • 1. Glycine Transporter 2: Mechanism and Allosteric Modulation.
    Frangos ZJ; Cantwell Chater RP; Vandenberg RJ
    Front Mol Biosci; 2021; 8():734427. PubMed ID: 34805268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane cholesterol regulates inhibition and substrate transport by the glycine transporter, GlyT2.
    Frangos ZJ; Wilson KA; Aitken HM; Cantwell Chater R; Vandenberg RJ; O'Mara ML
    Life Sci Alliance; 2023 Apr; 6(4):. PubMed ID: 36690444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of an allosteric binding site on the human glycine transporter, GlyT2, for bioactive lipid analgesics.
    Mostyn SN; Wilson KA; Schumann-Gillett A; Frangos ZJ; Shimmon S; Rawling T; Ryan RM; O'Mara ML; Vandenberg RJ
    Elife; 2019 Oct; 8():. PubMed ID: 31621581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the mechanism and pharmacology of neurotransmitter sodium symporters.
    Navratna V; Gouaux E
    Curr Opin Struct Biol; 2019 Feb; 54():161-170. PubMed ID: 30921707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of LeuT as a model in elucidating binding sites for substrates and inhibitors in neurotransmitter transporters.
    Loland CJ
    Biochim Biophys Acta; 2015 Mar; 1850(3):500-10. PubMed ID: 24769398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol binding to a conserved site modulates the conformation, pharmacology, and transport kinetics of the human serotonin transporter.
    Laursen L; Severinsen K; Kristensen KB; Periole X; Overby M; Müller HK; Schiøtt B; Sinning S
    J Biol Chem; 2018 Mar; 293(10):3510-3523. PubMed ID: 29352106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The allosteric inhibition of glycine transporter 2 by bioactive lipid analgesics is controlled by penetration into a deep lipid cavity.
    Wilson KA; Mostyn SN; Frangos ZJ; Shimmon S; Rawling T; Vandenberg RJ; O'Mara ML
    J Biol Chem; 2021; 296():100282. PubMed ID: 33450225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of a Putative Third Sodium Site in the Glycine Transporter GlyT2 Influences the Chloride Dependence of Substrate Transport.
    Benito-Muñoz C; Perona A; Abia D; Dos Santos HG; Núñez E; Aragón C; López-Corcuera B
    Front Mol Neurosci; 2018; 11():347. PubMed ID: 30319354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The allosteric mechanism of substrate-specific transport in SLC6 is mediated by a volumetric sensor.
    LeVine MV; Terry DS; Khelashvili G; Siegel ZS; Quick M; Javitch JA; Blanchard SC; Weinstein H
    Proc Natl Acad Sci U S A; 2019 Aug; 116(32):15947-15956. PubMed ID: 31324743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Determinants for Substrate Interactions with the Glycine Transporter GlyT2.
    Carland JE; Thomas M; Mostyn SN; Subramanian N; O'Mara ML; Ryan RM; Vandenberg RJ
    ACS Chem Neurosci; 2018 Mar; 9(3):603-614. PubMed ID: 29120604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of the Association between Na+ Binding and Conformations at the Intracellular Gate in Neurotransmitter:Sodium Symporters.
    Stolzenberg S; Quick M; Zhao C; Gotfryd K; Khelashvili G; Gether U; Loland CJ; Javitch JA; Noskov S; Weinstein H; Shi L
    J Biol Chem; 2015 May; 290(22):13992-4003. PubMed ID: 25869126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and Gating Dynamics of Na
    Joseph D; Pidathala S; Mallela AK; Penmatsa A
    Front Mol Biosci; 2019; 6():80. PubMed ID: 31555663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric Modulation of Neurotransmitter Transporters as a Therapeutic Strategy.
    Niello M; Gradisch R; Loland CJ; Stockner T; Sitte HH
    Trends Pharmacol Sci; 2020 Jul; 41(7):446-463. PubMed ID: 32471654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The substrate-driven transition to an inward-facing conformation in the functional mechanism of the dopamine transporter.
    Shan J; Javitch JA; Shi L; Weinstein H
    PLoS One; 2011 Jan; 6(1):e16350. PubMed ID: 21298009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring Substrate Binding in the Extracellular Vestibule of MhsT by Atomistic Simulations and Markov Models.
    Abramyan AM; Quick M; Xue C; Javitch JA; Shi L
    J Chem Inf Model; 2018 Jun; 58(6):1244-1252. PubMed ID: 29851339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steric hindrance mutagenesis in the conserved extracellular vestibule impedes allosteric binding of antidepressants to the serotonin transporter.
    Plenge P; Shi L; Beuming T; Te J; Newman AH; Weinstein H; Gether U; Loland CJ
    J Biol Chem; 2012 Nov; 287(47):39316-26. PubMed ID: 23007398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Templates and models of monoamine transporter proteins.
    Sylte I; Ravna AW; Dahl SG
    Curr Med Chem; 2011; 18(30):4651-8. PubMed ID: 21864275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of chloride interaction with neurotransmitter:sodium symporters.
    Zomot E; Bendahan A; Quick M; Zhao Y; Javitch JA; Kanner BI
    Nature; 2007 Oct; 449(7163):726-30. PubMed ID: 17704762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive structure-based alignment of prokaryotic and eukaryotic neurotransmitter/Na+ symporters (NSS) aids in the use of the LeuT structure to probe NSS structure and function.
    Beuming T; Shi L; Javitch JA; Weinstein H
    Mol Pharmacol; 2006 Nov; 70(5):1630-42. PubMed ID: 16880288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LeuT: a prokaryotic stepping stone on the way to a eukaryotic neurotransmitter transporter structure.
    Singh SK
    Channels (Austin); 2008; 2(5):380-9. PubMed ID: 19066470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.